» Articles » PMID: 25963142

The Microfibril-associated Glycoproteins (MAGPs) and the Microfibrillar Niche

Overview
Journal Matrix Biol
Publisher Elsevier
Date 2015 May 13
PMID 25963142
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

The microfibril-associated glycoproteins MAGP-1 and MAGP-2 are extracellular matrix proteins that interact with fibrillin to influence microfibril function. The two proteins are related through a 60 amino acid matrix-binding domain but their sequences differ outside of this region. A distinguishing feature of both proteins is their ability to interact with TGFβ family growth factors, Notch and Notch ligands, and multiple elastic fiber proteins. MAGP-2 can also interact with αvβ3 integrins via a RGD sequence that is not found in MAGP-1. Morpholino knockdown of MAGP-1 expression in zebrafish resulted in abnormal vessel wall architecture and altered vascular network formation. In the mouse, MAGP-1 deficiency had little effect on elastic fibers in blood vessels and lung but resulted in numerous unexpected phenotypes including bone abnormalities, hematopoietic changes, increased fat deposition, diabetes, impaired wound repair, and a bleeding diathesis. Inactivation of the gene for MAGP-2 in mice produced a neutropenia yet had minimal effects on bone or adipose homeostasis. Double knockouts had phenotypes characteristic of each individual knockout as well as several additional traits only seen when both genes are inactivated. A common mechanism underlying all of the traits associated with the knockout phenotypes is altered TGFβ signaling. This review summarizes our current understanding of the function of the MAGPs and discusses ideas related to their role in growth factor regulation.

Citing Articles

The Biomechanics of Fibrillin Microfibrils: Lessons from the Ciliary Zonule.

Rathaur P, Rodriguez J, Kuchtey J, Insignares S, Jones W, Kuchtey R Cells. 2025; 13(24.

PMID: 39768188 PMC: 11674075. DOI: 10.3390/cells13242097.


External Scaffold for Strengthening the Pulmonary Autograft in the Ross Procedure.

Nappi F, Nassif A, Schoell T Biomimetics (Basel). 2024; 9(11).

PMID: 39590246 PMC: 11591583. DOI: 10.3390/biomimetics9110674.


The potent potential of MFAP2 in prognosis and immunotherapy of triple-negative breast cancer.

Huang J, Xu Y, Qi S, Zheng Q, Cui C, Liu L Discov Oncol. 2024; 15(1):202.

PMID: 38822944 PMC: 11144179. DOI: 10.1007/s12672-024-01044-7.


Loci cg06256735 and cg15815843 in the MFAP5 gene regulatory regions are hypomethylated in varicose veins apparently due to active demethylation.

Smetanina M, Korolenya V, Sipin F, Oscorbin I, Sevostyanova K, Gavrilov K Biosci Rep. 2024; 44(5).

PMID: 38743016 PMC: 11139664. DOI: 10.1042/BSR20231938.


Enhanced Optic Nerve Expansion and Altered Ultrastructure of Elastic Fibers Induced by Lysyl Oxidase Inhibition in a Mouse Model of Marfan Syndrome.

Wu H, Krystofiak E, Kuchtey J, Kuchtey R Am J Pathol. 2024; 194(7):1317-1328.

PMID: 38548269 PMC: 11317902. DOI: 10.1016/j.ajpath.2024.03.002.


References
1.
Werneck C, Trask B, Broekelmann T, Trask T, Ritty T, Segade F . Identification of a major microfibril-associated glycoprotein-1-binding domain in fibrillin-2. J Biol Chem. 2004; 279(22):23045-51. DOI: 10.1074/jbc.M402656200. View

2.
Henderson M, Polewski R, Fanning J, Gibson M . Microfibril-associated glycoprotein-1 (MAGP-1) is specifically located on the beads of the beaded-filament structure for fibrillin-containing microfibrils as visualized by the rotary shadowing technique. J Histochem Cytochem. 1996; 44(12):1389-97. DOI: 10.1177/44.12.8985131. View

3.
Lou X, Kang B, Zhang J, Hao C, Tian X, Li W . MFAP3L activation promotes colorectal cancer cell invasion and metastasis. Biochim Biophys Acta. 2014; 1842(9):1423-32. DOI: 10.1016/j.bbadis.2014.04.006. View

4.
Murphy-Ullrich J, Sage E . Revisiting the matricellular concept. Matrix Biol. 2014; 37:1-14. PMC: 4379989. DOI: 10.1016/j.matbio.2014.07.005. View

5.
Graul-Neumann L, Hausser I, Essayie M, Rauch A, Kraus C . Highly variable cutis laxa resulting from a dominant splicing mutation of the elastin gene. Am J Med Genet A. 2008; 146A(8):977-83. DOI: 10.1002/ajmg.a.32242. View